Your browser doesn't support javascript.
loading
The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy.
Griñán-Ferré, Christian; Bellver-Sanchis, Aina; Izquierdo, Vanessa; Corpas, Rubén; Roig-Soriano, Joan; Chillón, Miguel; Andres-Lacueva, Cristina; Somogyvári, Milán; Soti, Csaba; Sanfeliu, Coral; Pallàs, Mercè.
Afiliação
  • Griñán-Ferré C; Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av Joan XXIII 27-31, 08028, Barcelona, Spain. Electronic address: Christian.grinan@ub.edu.
  • Bellver-Sanchis A; Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av Joan XXIII 27-31, 08028, Barcelona, Spain.
  • Izquierdo V; Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av Joan XXIII 27-31, 08028, Barcelona, Spain.
  • Corpas R; Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, IDIBAPS and CIBERESP, Barcelona, Spain.
  • Roig-Soriano J; Department of Biochemistry and Molecular Biology, Universitat Autònoma Barcelona, Institut de Neurociènces (INc), Universitat Autònoma Barcelona, Bellaterra, Spain.
  • Chillón M; Department of Biochemistry and Molecular Biology, Universitat Autònoma Barcelona, Institut de Neurociènces (INc), Universitat Autònoma Barcelona, Bellaterra, Spain; Vall d'Hebron Institut de Recerca (VHIR), Research Group on Gene Therapy at Nervous System, Passeig de la Vall d'Hebron, Barcelona, Spa
  • Andres-Lacueva C; Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Xarta, INSA, Faculty of Pharmacy and Food Sciences, Campus Torribera, University of Barcelona, Spain; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salut Carlos III, Barcelon
  • Somogyvári M; Department of Medical Chemistry, Semmelweis University, Budapest, Hungary.
  • Soti C; Department of Medical Chemistry, Semmelweis University, Budapest, Hungary.
  • Sanfeliu C; Institut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, IDIBAPS and CIBERESP, Barcelona, Spain.
  • Pallàs M; Pharmacology Section, Department of Pharmacology, Toxicology, and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av Joan XXIII 27-31, 08028, Barcelona, Spain.
Ageing Res Rev ; 67: 101271, 2021 05.
Article em En | MEDLINE | ID: mdl-33571701
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Ageing Res Rev Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Ageing Res Rev Ano de publicação: 2021 Tipo de documento: Article